• 1
    Jemal A, Clegg LX, Ward E, et al. Annual report to the nation on the status of cancer, 1975–2001, with a special feature regarding survival. Cancer. 2004; 101: 327.
  • 2
    Coia LR, Minsky BD, Berkey BA, et al. Outcome of patients receiving radiation for cancer of the esophagus: results of the 1992–1994 Patterns of Care Study. J Clin Oncol. 2000; 18: 455462.
  • 3
    Walsh TN, Noonan N, Hollywood D, et al. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med. 1996; 335: 462467.
  • 4
    Urba SG, Orringer MB, Turrisi A, et al. Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol. 2001; 19: 305313.
  • 5
    Bosset JF, Gignoux M, Triboulet JP, et al. Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. N Engl J Med. 1997; 337: 161167.
  • 6
    Kelsen DP, Ginsberg R, Pajak TF, et al. Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med. 1998; 339: 19791984.
  • 7
    Medical Research Council Oesophageal Cancer Working Group. Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial. Lancet. 2002; 359: 17271733.
  • 8
    Heath EI, Burtness BA, Heitmiller RF, et al. Phase II evaluation of preoperative chemoradiation and postoperative adjuvant chemotherapy for squamous cell and adenocarcinoma of the esophagus. J Clin Oncol. 2000; 18: 868876.
  • 9
    Forastiere AA, Orringer MB, Perez-Tamayo C, et al. Concurrent chemotherapy and radiation therapy followed by transhiatal esophagectomy for local-regional cancer of the esophagus. J Clin Oncol. 1990; 8: 119127.
  • 10
    Ajani JA, Komaki R, Putnam JB, et al. A three-step strategy of induction chemotherapy then chemoradiation followed by surgery in patients with potentially resectable carcinoma of the esophagus of gastroesophageal junction. Cancer. 2001; 92: 279286.
  • 11
    Ajani JA, Walsh G, Komaki R, et al. Preoperative induction CPT-11 and cisplatin chemotherapy followed by chemoradiotherapy in patients with local-regional carcinoma of the esophagus or gastroesophageal junction. Cancer. 2004; 100: 23472354.
  • 12
    Malthaner R, Fenlon D. Preoperative chemotherapy for resectable thoracic esophageal cancer. Cochrane Database Syst Rev. 2003; CD001556.
  • 13
    Darnton SJ, Archer VR, Stocken DD, et al. Preoperative mitomycin, ifosfamide, and cisplatin followed by esophagectomy in squamous cell carcinoma of the esophagus: pathologic complete response induced by chemotherapy leads to long-term survival. J Clin Oncol. 2003; 21: 40094015.
  • 14
    Meluch AA, Greco FA, Gray JR, et al. Preoperative therapy with concurrent paclitaxel/carboplatin/infusional 5-FU and radiation therapy in locoregional esophageal cancer: final results of a Minnie Pearl Cancer Research Network phase II trial. Cancer J. 2003; 9: 251260.
  • 15
    Poplin E, Fleming T, Leichman L, et al. Combined therapies for squamous-cell carcinoma of the esophagus, a Southwest Oncology Group Study (SWOG-8037). J Clin Oncol. 1987; 5: 622628.
  • 16
    Szumilo J, Chibowski D, Dabrowski A. Assessment of the predictive value of clinical and histopathological factors as well as the immunoexpression of p53 and bcl-2 proteins in the response to preoperative chemotherapy for esophageal squamous cell carcinoma. Dis Esophagus. 2000; 13: 191197.
  • 17
    Ganem G, Dubray B, Raoul Y, et al. Concomitant chemoradiotherapy followed, where feasible, by surgery for cancer of the esophagus. J Clin Oncol. 1997; 15: 701711.
  • 18
    Stahl M, Wilke H, Fink U, et al. Combined preoperative chemotherapy and radiotherapy in patients with locally advanced esophageal cancer. Interim analysis of a phase II trial. J Clin Oncol. 1996; 14: 829837.
  • 19
    Stockeld D, Tennvall J, Wagenius G, et al. A Swedish study of chemoradiation in squamous cell carcinoma of the esophagus. Acta Oncol. 2001; 40: 566573.
  • 20
    Vogel SB, Mendenhall WM, Sombeck MD. Downstaging of esophageal cancer after preoperative radiation and chemotherapy. Ann Surg. 1995; 221: 685695.
  • 21
    Forastiere AA, Heitmiller RF, Lee DJ, et al. Intensive chemoradiation followed by esophagectomy for squamous cell and adenocarcinoma of the esophagus. Cancer J Sci Am. 1997; 3: 144152.
  • 22
    Forastiere AA, Orringer MB, Perez-Tamayo C, et al. Preoperative chemoradiation followed by transhiatal esophagectomy for carcinoma of the esophagus: final report. J Clin Oncol. 1993; 11: 11181123.
  • 23
    Meneu-Diaz JC, Blazquez LA, Vicente E, et al. The role of multimodality therapy for resectable esophageal cancer. Am J Surg. 2000; 179: 508513.
  • 24
    Donington JS, Miller DL, Allen MS, et al. Tumor response to induction chemoradiation: influence on survival after esophagectomy. Eur J Cardiothorac Surg. 2003; 24: 631637.
  • 25
    De Vita F, Di Martino N, Orditura M, et al. Preoperative chemoradiotherapy for squamous cell carcinoma and adenocarcinoma of the esophagus: a phase II study. Chest. 2002; 122: 13021308.
  • 26
    Slater MS, Holland J, Faigel DO, et al. Does neoadjuvant chemoradiation downstage esophageal carcinoma? Am J Surg. 2001; 181: 440444.
  • 27
    Kim JH, Choi EK, Kim SB, et al. Preoperative hyperfractionated radiotherapy with concurrent chemotherapy in resectable esophageal cancer. Int J Radiat Oncol Biol Phys. 2001; 50: 112.
  • 28
    Imdahl A, Jenkner J, Ihling C, et al. Is MIB-1 proliferation index a predictor for response to neoadjuvant therapy in patients with esophageal cancer? Am J Surg. 2000; 179: 514520.
  • 29
    Makary MA, Kiernan PD, Sheridan MJ, et al. Multimodality treatment for esophageal cancer: the role of surgery and neoadjuvant therapy. Am Surg. 2003; 69: 693702.
  • 30
    Tsujinaka T, Shiozaki H, Yamamoto M, et al. Role of preoperative chemoradiation in the management of upper third thoracic esophageal squamous cell carcinoma. Am J Surg. 1999; 177: 503506.
  • 31
    Suntharalingam M, Haas ML, Sonett JR, et al. Accurate lymph node assessment prior to trimodality therapy for esophageal carcinoma. Cancer J. 2001; 7: 509515.
  • 32
    Green FL, Page DL, Fleming ID, et al. Esophagus. In: GreenFL, PageDL, FlemingID, et al., editors. AJCC cancer staging manual, 6th ed. New York: Springer-Verlag, 2002: 9198.
  • 33
    Ajani JA, Mansfield PF, Janjan N, et al. A multi-institutional trial of preoperative chemoradiotherapy in patients with potentially resectable gastric carcinoma. J Clin Oncol. 2004; 22: 27742780.
  • 34
    Ura T, Muro K, Shimada K, et al. Definitive chemoradiotherapy may be the standard treatment option in clinical stage I esophageal cancer [abstract 4017]. Proc Am Soc Clin Oncol. 2004; 23: 316.